by adminAdrianRamirez | Oct 23, 2018 | HempMeds, Press Releases
SAN DIEGO, Oct. 23, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has garnered news coverage in leading international publication Men’s Health....
by adminAdrianRamirez | Oct 17, 2018 | Kannaway, Press Releases
SAN DIEGO, Oct. 17, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), announced today that subsidiary Kannaway®, the first direct selling company to offer cannabidiol (CBD) hemp botanical products, has a new Kannaway® Connect app. The new mobile...
by adminAdrianRamirez | Oct 16, 2018 | HempMeds, Press Releases
SAN DIEGO, Oct. 16, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at...
by adminAdrianRamirez | Oct 15, 2018 | HempMeds Brasil, Press Releases
SAN DIEGO, Oct. 15, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that an executive from its subsidiary HempMeds® Brasil spoke on the benefits of cannabidiol (CBD) hemp...
by adminAdrianRamirez | Oct 11, 2018 | HempMeds, Press Releases
SAN DIEGO, Oct. 11, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the company’s Chief Executive Officer Dr. Stuart Titus will speak about Humulus-derived cannabidiol...